Theratechnologies Accounts Payable vs Short Long Term Debt Total Analysis

TH Stock

CAD 1.71 0.02 1.16%

Theratechnologies financial indicator trend analysis is much more than just breaking down Theratechnologies prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Theratechnologies is a good investment. Please check the relationship between Theratechnologies Accounts Payable and its Short Long Term Debt Total accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.

Accounts Payable vs Short Long Term Debt Total

Accounts Payable vs Short Long Term Debt Total Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Theratechnologies Accounts Payable account and Short Long Term Debt Total. At this time, the significance of the direction appears to have strong relationship.

The correlation between Theratechnologies' Accounts Payable and Short Long Term Debt Total is 0.65. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Short Long Term Debt Total in the same time period over historical financial statements of Theratechnologies, assuming nothing else is changed. The correlation between historical values of Theratechnologies' Accounts Payable and Short Long Term Debt Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Theratechnologies are associated (or correlated) with its Short Long Term Debt Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Short Long Term Debt Total has no effect on the direction of Accounts Payable i.e., Theratechnologies' Accounts Payable and Short Long Term Debt Total go up and down completely randomly.

Correlation Coefficient

0.65

Relationship Direction	Positive
Relationship Strength	Significant

View All Relationships

Accounts Payable

An accounting item on the balance sheet that represents Theratechnologies obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Theratechnologies are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Short Long Term Debt Total

Most indicators from Theratechnologies' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Theratechnologies current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.At this time, Theratechnologies' Selling General Administrative is very stable compared to the past year. As of the 2nd of June 2024, Tax Provision is likely to grow to about 508.4 K, while Issuance Of Capital Stock is likely to drop about 16.3 M.

	2021	2022	2023	2024 (projected)
Gross Profit	53.8M	62.1M	71.4M	75.0M
Total Revenue	80.1M	81.8M	94.0M	98.7M

Gross Profit Total Revenue

Theratechnologies fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Term Debt	Intangible Assets	Other Current Liab	Short Term Investments	Other Assets
Total Assets		0.75	0.63	-0.1	0.42	0.79	-0.57	0.94	0.68	0.79	0.58	0.92	0.79	0.63	0.75	0.67	0.7	-0.22	0.84	0.45	0.94	0.27	0.77	0.67	0.49	0.38
Short Long Term Debt Total	0.75		0.8	-0.67	0.5	0.87	-0.81	0.65	0.88	0.48	0.28	0.74	0.91	0.31	0.8	0.35	0.91	-0.19	0.97	0.69	0.9	0.77	0.42	0.31	0.17	0.82
Total Current Liabilities	0.63	0.8		-0.68	0.58	0.84	-0.71	0.6	0.61	0.31	0.09	0.61	0.77	0.48	0.35	0.39	0.78	-0.21	0.84	0.71	0.75	0.73	0.35	0.49	0.26	0.77
Total Stockholder Equity	-0.1	-0.67	-0.68		-0.54	-0.57	0.59	-0.07	-0.49	0.23	0.33	-0.16	-0.55	0.15	-0.28	0.09	-0.65	0.16	-0.6	-0.73	-0.35	-0.87	0.07	0.08	0.16	-0.83
Property Plant And Equipment Net	0.42	0.5	0.58	-0.54		0.74	-0.22	0.57	0.29	0.05	-0.18	0.35	0.52	0.03	0.33	0.46	0.59	-0.13	0.56	0.94	0.5	0.3	0.26	0.5	0.44	0.28
Net Debt	0.79	0.87	0.84	-0.57	0.74		-0.73	0.8	0.61	0.52	0.13	0.66	0.85	0.49	0.67	0.64	0.87	-0.19	0.92	0.81	0.86	0.55	0.57	0.61	0.32	0.61
Retained Earnings	-0.57	-0.81	-0.71	0.59	-0.22	-0.73		-0.4	-0.54	-0.35	-0.01	-0.49	-0.66	-0.52	-0.54	-0.38	-0.78	0.01	-0.76	-0.43	-0.66	-0.68	-0.33	-0.31	0.11	-0.74
Accounts Payable	0.94	0.65	0.6	-0.07	0.57	0.8	-0.4		0.56	0.76	0.53	0.83	0.74	0.6	0.66	0.73	0.6	-0.25	0.76	0.52	0.86	0.11	0.74	0.71	0.53	0.24
Cash	0.68	0.88	0.61	-0.49	0.29	0.61	-0.54	0.56		0.45	0.54	0.82	0.84	0.08	0.8	0.06	0.73	-0.25	0.85	0.5	0.83	0.71	0.31	0.09	0.24	0.74
Non Current Assets Total	0.79	0.48	0.31	0.23	0.05	0.52	-0.35	0.76	0.45		0.66	0.61	0.57	0.63	0.64	0.6	0.35	-0.06	0.56	0.05	0.68	0.0	0.78	0.45	0.34	0.12
Non Currrent Assets Other	0.58	0.28	0.09	0.33	-0.18	0.13	-0.01	0.53	0.54	0.66		0.66	0.29	0.25	0.43	0.15	0.02	-0.13	0.3	-0.19	0.45	-0.04	0.4	0.1	0.17	-0.01
Cash And Short Term Investments	0.92	0.74	0.61	-0.16	0.35	0.66	-0.49	0.83	0.82	0.61	0.66		0.79	0.42	0.72	0.4	0.68	-0.31	0.8	0.43	0.91	0.38	0.58	0.5	0.51	0.48
Net Receivables	0.79	0.91	0.77	-0.55	0.52	0.85	-0.66	0.74	0.84	0.57	0.29	0.79		0.29	0.8	0.29	0.86	-0.31	0.95	0.69	0.91	0.68	0.55	0.33	0.41	0.79
Common Stock Shares Outstanding	0.63	0.31	0.48	0.15	0.03	0.49	-0.52	0.6	0.08	0.63	0.25	0.42	0.29		0.16	0.78	0.34	-0.08	0.4	0.01	0.5	-0.07	0.58	0.76	0.18	0.09
Non Current Liabilities Total	0.75	0.8	0.35	-0.28	0.33	0.67	-0.54	0.66	0.8	0.64	0.43	0.72	0.8	0.16		0.35	0.73	-0.21	0.8	0.46	0.82	0.41	0.59	0.24	0.28	0.5
Inventory	0.67	0.35	0.39	0.09	0.46	0.64	-0.38	0.73	0.06	0.6	0.15	0.4	0.29	0.78	0.35		0.42	0.01	0.45	0.34	0.55	-0.18	0.67	0.89	0.31	-0.09
Other Current Assets	0.7	0.91	0.78	-0.65	0.59	0.87	-0.78	0.6	0.73	0.35	0.02	0.68	0.86	0.34	0.73	0.42		-0.2	0.92	0.79	0.88	0.7	0.4	0.5	0.38	0.77
Other Stockholder Equity	-0.22	-0.19	-0.21	0.16	-0.13	-0.19	0.01	-0.25	-0.25	-0.06	-0.13	-0.31	-0.31	-0.08	-0.21	0.01	-0.2		-0.25	-0.15	-0.27	-0.12	-0.37	-0.16	-0.35	-0.3
Total Liab	0.84	0.97	0.84	-0.6	0.56	0.92	-0.76	0.76	0.85	0.56	0.3	0.8	0.95	0.4	0.8	0.45	0.92	-0.25		0.72	0.95	0.7	0.57	0.45	0.33	0.78
Property Plant And Equipment Gross	0.45	0.69	0.71	-0.73	0.94	0.81	-0.43	0.52	0.5	0.05	-0.19	0.43	0.69	0.01	0.46	0.34	0.79	-0.15	0.72		0.62	0.58	0.2	0.41	0.4	0.55
Total Current Assets	0.94	0.9	0.75	-0.35	0.5	0.86	-0.66	0.86	0.83	0.68	0.45	0.91	0.91	0.5	0.82	0.55	0.88	-0.27	0.95	0.62		0.51	0.64	0.59	0.5	0.61
Short Term Debt	0.27	0.77	0.73	-0.87	0.3	0.55	-0.68	0.11	0.71	0.0	-0.04	0.38	0.68	-0.07	0.41	-0.18	0.7	-0.12	0.7	0.58	0.51		0.01	-0.13	-0.05	0.95
Intangible Assets	0.77	0.42	0.35	0.07	0.26	0.57	-0.33	0.74	0.31	0.78	0.4	0.58	0.55	0.58	0.59	0.67	0.4	-0.37	0.57	0.2	0.64	0.01		0.58	0.42	0.16
Other Current Liab	0.67	0.31	0.49	0.08	0.5	0.61	-0.31	0.71	0.09	0.45	0.1	0.5	0.33	0.76	0.24	0.89	0.5	-0.16	0.45	0.41	0.59	-0.13	0.58		0.59	-0.01
Short Term Investments	0.49	0.17	0.26	0.16	0.44	0.32	0.11	0.53	0.24	0.34	0.17	0.51	0.41	0.18	0.28	0.31	0.38	-0.35	0.33	0.4	0.5	-0.05	0.42	0.59		0.03
Other Assets	0.38	0.82	0.77	-0.83	0.28	0.61	-0.74	0.24	0.74	0.12	-0.01	0.48	0.79	0.09	0.5	-0.09	0.77	-0.3	0.78	0.55	0.61	0.95	0.16	-0.01	0.03

Click cells to compare fundamentals

Theratechnologies Account Relationship Matchups

Theratechnologies fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	100.1M	119.2M	93.3M	77.8M	89.4M	65.2M
Short Long Term Debt Total	50.7M	55.4M	56.7M	66.7M	76.7M	80.6M
Total Current Liabilities	41.9M	45.1M	114.3M	47.3M	54.4M	57.1M
Total Stockholder Equity	3.2M	17.8M	(22.6M)	(20.9M)	(18.8M)	(17.8M)
Property Plant And Equipment Net	3.5M	2.9M	3.1M	2.0M	1.8M	1.3M
Net Debt	42.6M	36.3M	42.9M	23.9M	27.5M	28.8M
Retained Earnings	(300.1M)	(335.2M)	(382.6M)	(408.7M)	(367.8M)	(349.4M)
Accounts Payable	17.5M	15.5M	12.9M	7.0M	8.0M	6.4M
Cash	12.7M	20.4M	23.9M	34.1M	39.2M	41.2M
Non Current Assets Total	35.3M	27.3M	19.9M	14.5M	16.6M	29.9M
Non Currrent Assets Other	17.1M	12.2M	621K	1.8M	1.6M	1.5M
Cash And Short Term Investments	40.6M	20.8M	40.4M	33.1M	38.0M	20.2M
Net Receivables	13.2M	10.9M	12.3M	12.8M	14.7M	15.5M
Common Stock Shares Outstanding	77.0M	92.4M	95.3M	46.0M	52.9M	56.7M
Liabilities And Stockholders Equity	117.6M	100.1M	119.2M	93.3M	107.2M	62.9M
Non Current Liabilities Total	55.0M	56.4M	1.6M	51.3M	59.0M	62.0M
Inventory	25.1M	29.1M	19.7M	6.1M	7.0M	7.8M
Other Current Assets	4.5M	5.7M	11.5M	8.3M	9.5M	10.0M
Other Stockholder Equity	15.2M	16.5M	17.3M	20.9M	18.8M	17.9M
Total Liab	96.9M	101.5M	115.8M	98.6M	113.4M	119.1M
Property Plant And Equipment Gross	3.5M	3.6M	3.9M	3.2M	2.9M	3.0M
Total Current Assets	64.8M	91.9M	73.4M	63.3M	72.8M	76.4M
Accumulated Other Comprehensive Income	21K	(481K)	(44K)	385K	442.8K	464.9K
Short Term Debt	20.6M	425K	463K	65.3M	75.1M	78.8M
Intangible Assets	31.9M	23.8M	15.0M	12.5M	14.4M	12.3M
Other Current Liab	23.9M	58.1M	36.1M	1.5M	1.7M	1.6M
Short Term Investments	8.0M	20.0M	9.2M	6.3M	5.7M	9.9M
Current Deferred Revenue	70K	50K	54K	38K	34.2K	32.5K
Net Tangible Assets	(14.9M)	(28.6M)	(6.1M)	(37.6M)	(33.8M)	(32.1M)
Common Stock	287.0M	287.3M	335.8M	338.8M	389.6M	298.8M
Property Plant Equipment	1.1M	3.5M	2.9M	3.1M	3.6M	3.7M
Long Term Debt	52.4M	54.2M	0.0	50.7M	58.3M	34.4M
Long Term Debt Total	55.3M	55.0M	56.3M	1.4M	1.7M	1.6M
Capital Surpluse	10.8M	12.1M	12.8M	18.8M	21.6M	12.7M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Theratechnologies offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Theratechnologies' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Theratechnologies Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Theratechnologies Stock:

How To Invest In Theratechnologies

Details

Is Theratechnologies Stock a good investment?

Details

What is Theratechnologies' Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Theratechnologies. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in estimate.

To learn how to invest in Theratechnologies Stock, please use our How to Invest in Theratechnologies guide.

You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Complementary Tools for Theratechnologies Stock analysis

When running Theratechnologies' price analysis, check to measure Theratechnologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Theratechnologies is operating at the current time. Most of Theratechnologies' value examination focuses on studying past and present price action to predict the probability of Theratechnologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Theratechnologies' price. Additionally, you may evaluate how the addition of Theratechnologies to your portfolios can decrease your overall portfolio volatility.

	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets
	Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market.
	Risk-Return Analysis View associations between returns expected from investment and the risk you assume
	Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios
	Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
	Analyst Advice Analyst recommendations and target price estimates broken down by several categories
	Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
	Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk
	Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets

Please note, there is a significant difference between Theratechnologies' value and its price as these two are different measures arrived at by different means. Investors typically determine if Theratechnologies is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Theratechnologies' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Theratechnologies Accounts Payable vs Short Long Term Debt Total Analysis

Accounts Payable vs Short Long Term Debt Total

Accounts Payable vs Short Long Term Debt Total Correlation Analysis

Correlation Coefficient

Accounts Payable

Short Long Term Debt Total

Theratechnologies fundamental ratios Correlations

Theratechnologies Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Theratechnologies fundamental ratios Accounts

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

Complementary Tools for Theratechnologies Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Liab	+ 0.97	Short Long Term Debt Total
Total Liab	+ 0.95	Net Receivables
Total Current Assets	+ 0.95	Total Liab
Other Assets	+ 0.95	Short Term Debt
Accounts Payable	+ 0.94	Total Assets
Total Current Assets	+ 0.94	Total Assets

Short Term Debt	- 0.87	Total Stockholder Equity
Other Assets	- 0.83	Total Stockholder Equity
Retained Earnings	- 0.81	Short Long Term Debt Total
Other Current Assets	- 0.78	Retained Earnings
Total Liab	- 0.76	Retained Earnings
Other Assets	- 0.74	Retained Earnings